A biotechnology company developing antibodies grown in ostrich eggs is partnering with a Boston hospital to test a new treatment for Clostridium difficile, or C. difficile, a stubborn infection, increasingly resistant to antibiotics, and often contracted in hospitals. . . . → Read More: Ostrich Antibodies to Fight Resistant Infections
|
|||||
|
|
 Comments are closed  Joint ventures/collaborations, New products  Asia, biomedical, biotechnology, Japan, life sciences, pharmaceuticals, preclinical, university A designer of liquid biopsy tests to diagnose cancer is establishing a lab to study circulating tumor cells at John Wayne Cancer Institute in Santa Monica, California. . . . → Read More: Liquid Biopsy Lab to Reside at Cancer Institute Comments are closed Joint ventures/collaborations Asia, biomedical, cancer, engineering, life sciences, medical device, software, university Teva Pharmaceutical Industries is licensing from biotechnology company Regeneron Pharmaceuticals an engineered antibody that targets proteins supporting pain signals. . . . → Read More: Teva Licenses Pain Relief Antibody for $1.25 Billion Comments are closed Intellectual property, Joint ventures/collaborations Asia, biomedical, biotechnology, clinical trials, Israel, licensing, life sciences, pharmaceuticals Takeda Pharmaceutical Company is receiving $19.8 million from a U.S. public health agency for initial steps to develop a vaccine to prevent Zika infections. . . . → Read More: Takeda Awarded $19.8 Million for Zika Vaccine Comments are closed Finance Asia, biomedical, clinical trials, FDA, grant, Japan, life sciences, pharmaceuticals, preclinical A new challenge seeks technologies and solutions to reduce child mortality and improve the health of children in low-resource regions of the world. . . . → Read More: $1 Million Challenge Seeks Child Health Solutions One comment - (Comments are closed) Finance Africa, Asia, biomedical, challenge, engineering, life sciences, medical device, software (Greyerbaby, Pixabay) 11 August 2015. A clinical study of cellular treatments for women using in-vitro fertilization shows the treatments increased pregnancy rates compared to women receiving standard IVF alone. Findings from the study that tested treatments developed by IVF technology company OvaScience Inc. in Cambridge, Massachusetts are scheduled to be published on 25 August . . . → Read More: Trial Shows Fertility Treatment Boosts IVF Pregnancy Rate Comments are closed Regulations Asia, biomedical, biotechnology, clinical trials, life sciences, medical device, university Rocket Lab CEO Peter Beck with Electron rocket (Rocket Lab Ltd) 2 July 2015. Rocket Lab Ltd, a company aiming to make orbital space launches frequent and less costly, says it plans to build a launch site in New Zealand, with completion scheduled by the end of 2015. The company says test flights will . . . → Read More: Commercial Space Launch Site Slated for New Zealand Comments are closed New products Asia, engineering, entrepreneurs, manufacturing, materials science, physical sciences, physics, space, venture capital Stefan Bossmann, left, and Deryl Troyer (Kansas State University) 16 June 2015. Three researchers at Kansas State University in Manhattan received a patent for an early-stage test that the inventors say can diagnose some solid tumor cancers well before symptoms develop. Kansas State chemistry professor Stefan Bossmann and anatomy-physiology professor Deryl Troyer, with postdoctoral . . . → Read More: Patent Awarded for Early, Pre-Symptom Cancer Tests Comments are closed Intellectual property Asia, biomedical, biotechnology, cancer, chemistry, China, clinical trials, life sciences, medical device, nanotechnology, patent, physical sciences, university, USPTO Microscopic image of needle-like gout crystals (Bobjgalindo, Wikimedia Commons) 10 June 2015. An early-stage clinical trial is recruiting patients to test the safety of a treatment for severe gout that harnesses the immune system, but still avoids unwanted immune responses. The trial is conducted by the biotechnology company Selecta Biosciences at two sites in . . . → Read More: Trial Underway Testing Immunotherapy for Gout Comments are closed New products, Regulations Asia, biomedical, biotechnology, China, clinical trials, licensing, life sciences, nanotechnology, pharmaceuticals (Centers for Disease Control and Prevention) 2 June 2015. Drug maker Astellas Pharma Inc. in Tokyo and Anokion SA, a biotechnology company in Lausanne, Switzerland, are forming Kanyos Bio Inc., a spin-off enterprise to develop therapy candidates for autoimmune diseases. The deal could bring Kanyos Bio, based in Cambridge, Massachusetts, as much as $760 . . . → Read More: Spin-Off Biotech Formed for Autoimmune Disorders One comment - (Comments are closed) Finance, Intellectual property, Joint ventures/collaborations Asia, biomedical, biotechnology, entrepreneurs, equity, Europe, investment, Japan, licensing, life sciences, pharmaceuticals, venture capital |
A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2017 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
